Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GS-1191 by Gritgen Therapeutics for Hemophilia A (Factor VIII Deficiency): Likelihood of Approval
GS-1191 is under clinical development by Gritgen Therapeutics and currently in Phase I for Hemophilia A (Factor VIII Deficiency). According...